A discovery about the earliest stages of brain development has helped researchers grow specialised nerve cells in the laboratory. It could give scientists a more useful starting point for investigating neurological disease.
Before scientists can investigate why a particular nerve cell fails, they need a way to study it. For some cells in the hindbrain, producing a convincing laboratory counterpart has been a difficult part of that work.
A Stanford-led study offers a possible explanation for the difficulty: researchers may have been starting from the wrong developmental pathway. By looking back to the cells that first give rise to different brain regions, the team found a route to producing specialised hindbrain motor neurons from human stem cells.
The discovery, covered in Innovation News Network’s initial report, connects a question about the brain’s origins with a practical problem in disease research.
Following the brain back to its beginnings
The study, published in Nature Neuroscience on 18 September 2026, used lineage tracing in mouse embryos to follow what early cells became as development progressed. The results supported two populations of neural progenitors emerging during gastrulation, an early stage of embryonic development.
One population contributed to the forebrain and midbrain, while the other contributed to the hindbrain. Experiments with human pluripotent stem cells also found distinct commitments towards those regional identities.
This concerns the developmental origins of brain regions, rather than the left and right hemispheres. For the laboratory work, the important point is that the starting population influences which cells can be produced from it.
Turning a developmental finding into laboratory cells
According to Stanford’s account of the research, the team used that understanding to generate functional hindbrain motor neurons. The cells produced characteristic proteins and showed electrical activity, providing evidence of their identity and function.
Stanford identifies amyotrophic lateral sclerosis and spinal muscular atrophy as potential areas of investigation. The researchers want to understand how these conditions impair hindbrain neurons, and the ability to grow relevant cells could help them examine that question.
A cell-production method still needs to be evaluated for the task a researcher has in mind. Establishing that a cell has certain characteristics is one step; showing that it reproduces a feature of disease is another. The study does not establish a treatment for patients.
From growing cells to understanding disease
One possible next step would be to compare cells derived from suitable patient and control material, testing whether the laboratory model captures a difference relevant to the disease. That would require its own experiments, including checks that the result is consistent across the cell lines being studied.
Such work would connect the developmental finding to the question that prompted it: how can researchers study the particular cells they need? The promise is a way to make those experiments more specific. If the cells reliably reproduce a disease-relevant feature, scientists could investigate how that feature arises and what changes it. Understanding where a neuron comes from would then help reveal what happens when it goes wrong.
Team Health Accessible
Health & Wellness Editorial Team
HealthAccessible editorial team delivers trusted, accessible, and evidence-based health information for everyone.
